- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Stage IIB Non-Small Cell Lung Carcinoma in India
Total 123 results
-
NovaRx CorporationCompletedLung Neoplasm | Carcinoma Non-small Cell Lung Cancer Stage IIIA | Carcinoma Non-small Cell Lung Cancer Stage IIIB | Carcinoma Non-small Cell Lung Cancer Stage IVUnited States, Hungary, United Kingdom, Netherlands, Canada, India, Poland, Serbia
-
BioMarck Pharmaceuticals, Ltd.CompletedNon Small Cell Lung Cancer Stage IIIBIndia
-
CytRxTerminatedStage IV Non-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer With Pleural EffusionUnited States, Mexico, India, Ukraine, Bulgaria, Russian Federation
-
Samsung Bioepis Co., Ltd.RecruitingNon-small Cell Lung Cancer Stage IVGeorgia, India, Romania, Spain
-
AstraZenecaActive, not recruitingNon Small Cell Lung Cancer (Stage III)United States, Spain, Taiwan, Thailand, Vietnam, Turkey, Korea, Republic of, Brazil, Hungary, India, Japan, Mexico, Peru, Russian Federation, China, Malaysia, Argentina
-
Tata Memorial HospitalRecruitingNon-small Cell Lung Cancer | Oligometastatic Disease | Driver MutationIndia
-
Tata Memorial HospitalRecruitingOligometastatic Disease | Metastatic Non Small Cell Lung CancerIndia
-
Tata Memorial HospitalUnknownSmall Cell Lung Cancer | Non Small Cell Lung CancerIndia
-
Boehringer IngelheimCompletedNon-small Cell Lung CancerIndia
-
AstraZenecaCompletedUnresectable Non-small Cell Lung Cancer (NSCLC) and Urothelial CancerIndia
-
Peregrine PharmaceuticalsCompletedNon-small Cell Lung CancerIndia
-
PfizerCompletedMetastatic Non Small Cell Lung CancerIndia
-
AstraZenecaCompleted
-
Eli Lilly and CompanyCompletedNon-Small-Cell Lung CancerUnited States, India
-
PfizerCompletedAdvanced Non-Small Cell Lung CancerIndia
-
Bristol-Myers SquibbCompletedKidney Cancer | Kidney Neoplasms | Nonsmall Cell Lung Cancer | Renal Cancer | Non-Small-Cell Lung Carcinoma | Non-Small Cell Lung Cancer (NSCLC) | Renal NeoplasmsIndia
-
Cadila PharnmaceuticalsCompletedNon Small Cell Lung CancerIndia
-
AstraZenecaCompletedNon-small Cell Lung CancerTurkey, Hong Kong, Australia, Egypt, India, Kuwait, United Arab Emirates
-
Daiichi Sankyo, Inc.CompletedAdvanced Non-small Cell Lung Cancer (NSCLC)Korea, Republic of, United States, India, Germany
-
BiocadCompletedNon-small Cell Lung CancerUkraine, Belarus, India, Russian Federation
-
Eli Lilly and CompanyCompletedNon-Small-Cell Lung CancerUnited Kingdom, Taiwan, Brazil, China, India, Korea, Republic of, Hong Kong
-
Hoffmann-La RocheCompleted
-
Eli Lilly and CompanyCompletedNon Small Cell Lung CarcinomaBelgium, France, Germany, Portugal, Spain, Sweden, Italy, United States, Canada, Netherlands, Argentina, Australia, Austria, Brazil, Denmark, Finland, Greece, Hungary, India, Israel, Korea, Republic of, Mexico, Poland, Puerto Rico, Taiwan, Turk... and more
-
AstraZenecaCompletedNon-small-cell Lung Cancer (NSCLC)Mexico, Peru, Argentina, Taiwan, India, Thailand, Colombia, Uruguay, Chile, Dominican Republic
-
AstraZenecaCompletedNon-small Cell Lung CancerVietnam, Turkey, Philippines, Thailand, Egypt, Singapore, India, Peru, Argentina, Chile, Colombia, Costa Rica, Dominican Republic, Kuwait, Mexico
-
AstraZenecaCompletedNon Small Cell Lung CancerVietnam, Philippines, China, Hong Kong, Taiwan, Thailand, India
-
Peregrine PharmaceuticalsCompletedNon-Squamous Non-Small Cell Lung CancerUnited States, India, Georgia, Russian Federation, Ukraine
-
Prestige Biopharma LimitedActive, not recruitingLung Cancer | Non-small Cell Lung CancerIndia, Hungary, Georgia, Philippines, Belarus, Bulgaria, Croatia, Greece, Latvia, Malaysia, Poland, Russian Federation, Serbia, Slovakia, Thailand, Turkey, Ukraine
-
Daiichi Sankyo, Inc.CompletedMetastatic Non-small Cell Lung CancerUnited States, India, Poland, Romania
-
SK Chemicals Co., Ltd.Completed
-
International Atomic Energy AgencyCompletedNon Small Cell Lung CancerChile, China, Croatia, Egypt, India, Malaysia, Malta, Morocco, Pakistan, Panama, Peru, South Africa, Tunisia
-
AstraZenecaActive, not recruitingNon Small Cell Lung Carcinoma NSCLCDenmark, United Kingdom, United States, Poland, Brazil, India, Japan, Mexico, Peru, Russian Federation, Turkey, China, Malaysia, Hong Kong, Korea, Republic of, Chile, Israel, Ukraine, Portugal, Greece, Bulgaria, Philippines, Sweden, A... and more
-
Peregrine PharmaceuticalsCompletedNon-small-cell Lung CancerUnited States, India, Georgia, Russian Federation, Ukraine
-
AstraZenecaApproved for marketingNon Small Cell Lung Cancer (NSCLC)Taiwan, Thailand, Turkey, Brazil, Philippines, Russian Federation, Romania, Austria, Hungary, Bulgaria, Latvia, India, Argentina, Australia, Estonia, Malaysia, Mexico, Singapore, South Africa
-
Eli Lilly and CompanyCompletedCarcinoma, Non-Small Cell LungChina, Taiwan, Australia, Korea, Republic of, Egypt, Romania, India, Turkey
-
Novartis PharmaceuticalsTerminatedNon-small Cell Lung Cancer (NSCLC)Japan, Germany, Spain, Italy, France, Thailand, Belgium, Netherlands, India, Malaysia, Taiwan, Australia, Canada, Czechia, Greece, Hong Kong
-
Novartis PharmaceuticalsRecruitingNon-Small Cell Lung CarcinomaIndia
-
Spectrum Pharmaceuticals, IncCompletedNon-small Cell Lung CancerUnited States, Czechia, India, Brazil, Argentina, Hungary
-
BayerCompletedCarcinoma | Non-Small-Cell LungItaly, Spain, China, Korea, Republic of, Bulgaria, Turkey, Greece, Philippines, Taiwan, Russian Federation, Hungary, Singapore, France, Netherlands, Sweden, Belgium, United States, Austria, Thailand, Germany, Israel, Poland, Canada, United... and more
-
PfizerActive, not recruitingCarcinoma | Non-Small-Cell LungSpain, United States, United Kingdom, Italy, India, Poland, Switzerland
-
Merck Sharp & Dohme LLCRecruitingLung Neoplasms | Non-Small-Cell Lung CarcinomaUnited States, Brazil, Canada, Chile, China, Guatemala, Hong Kong, Hungary, Japan, Korea, Republic of, Malaysia, Mexico, Peru, Russian Federation, South Africa, Taiwan, Thailand, Ukraine, Romania, Dominican Republic, Philippines, ... and more
-
AstraZenecaActive, not recruitingNon-Small Cell Lung CancerUnited States, Argentina, India, Taiwan, Thailand, Vietnam
-
mAbxience Research S.L.CompletedNon-small Cell Lung CancerPhilippines, Hungary, Chile, Mexico, Spain, Serbia, Malaysia, Brazil, Bulgaria, Georgia, Greece, India, Lebanon, Oman, Russian Federation, Thailand, Turkey, Ukraine
-
AstraZenecaActive, not recruitingNon-small Cell Lung Cancer NSCLCUnited Kingdom, Belgium, United States, Korea, Republic of, Hungary, Japan, Russian Federation, Poland, Ukraine, India, Mexico, Netherlands
-
Novartis PharmaceuticalsNo longer availableNon-small Cell Lung Cancer (NSCLC)United States, Argentina, Korea, Republic of, Hong Kong, Thailand, Mexico, Jordan, Colombia, India, Philippines
-
Eli Lilly and CompanyCompletedNon Small Cell Lung CancerIndia, Turkey, China, United States, Germany, Spain, Taiwan, Belgium, Korea, Republic of, France, Greece, Netherlands, United Kingdom, Australia, Canada, Brazil, Ireland, Portugal, Argentina
-
Genzyme, a Sanofi CompanyCompletedLung Cancer | Non Small Cell Lung CancerUnited States, Australia, France, Italy, South Africa, Spain, United Kingdom, Sweden, Philippines, Germany, Hong Kong, Argentina, Israel, Portugal, Greece, Taiwan, Mexico, Belgium, Venezuela, Colombia, India
-
Genzyme, a Sanofi CompanyCompletedNon Small Cell Lung CancerUnited States, Australia, Brazil, France, Italy, Korea, Republic of, Mexico, Spain, United Kingdom, Philippines, China, Germany, Norway, Canada, Hong Kong, Argentina, Netherlands, Taiwan, India, Thailand, Indonesia, Denmark
-
Genzyme, a Sanofi CompanyCompletedLung Cancer | Non-small Cell Lung CancerVietnam, United States, Brazil, France, Italy, Korea, Republic of, Mexico, Spain, Turkey, Germany, China, Japan, Netherlands, Argentina, Austria, Belgium, Canada, Portugal, Greece, India, Denmark, Malaysia, Indonesia, Thailand, Singapore